Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 226

Surrozen generates $50m series B

Based on Stanford research, Surrozen is working on regenerative treatments for a wide range of conditions, with a first focus on liver disease.

Mar 22, 2019

Tarana wires in $88m

AT&T and Deutsche Telekom-backed wireless internet system developer Tarana added $60m from investors including EchoStar to close the round.

Mar 22, 2019

Markforged assembles $82m in series D funding

Microsoft subsidiary M12, Siemens' Next47 fund and Porsche all invested in the industrial 3D printer producer's latest round, which lifted its overall funding to $139m.

Mar 22, 2019

Splice tunes into series C funding

The WME and AM Only-backed music production platform has now raised approximately $100m in total, following a $57.5m round co-led by True Ventures and USV.

Mar 22, 2019

Ojo Labs gets $45m result

The real estate-focused chatbot developer has now raised more than $71m in total, having secured series C funding from investors including Realogy, Royal Bank of Canada and Northwestern Mutual.

Mar 21, 2019

Mojo Vision moves to $58m series B

LG, HP Tech Ventures, Motorola Solutions Venture Capital, Kakao Ventures and Gradient Ventures all invested, four months after the AR startup's $50m series A.

Mar 20, 2019

Instarem increases series C round to $41m

The financial remittance service has added $21m to more than double a series C round that included Telkom Indonesia, Kasikorn Bank, Rocket Internet and SBI.

Mar 20, 2019

Mojo Vision sets $58m series B scene

Stanford-StartX has contributed to a $58m series B for AR platform Mojo Vision, which also attracted Google, HP, Motorola Solutions, LG and Kakao.

Mar 20, 2019

Carro drives series B round to $90m

SoftBank Ventures Asia was among the returning investors that helped add $30m to a $60m first tranche that included Singtel Innov8.

Mar 19, 2019

Imara imports $63m in series B funding

The sickle cell disease therapy developer boosted its overall funding to $94m in a round backed by Lundbeck, Pfizer and Alexandria Real Estate Equities.

Mar 19, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here